Rating Change
Morgan Stanley analysts reiterated a Overweight rating on Zoetis Inc. (NYSE:ZTS) on July 22, 2026.
reiterateNYSE:ZTS
Morgan Stanley Reiterates Overweight Rating on Zoetis Inc. (ZTS)
Rating Change Morgan Stanley analysts reiterated a Overweight rating on Zoetis Inc. (NYSE:ZTS) on July 22, 2026. Market Context Zoetis Inc.
Market Context
Zoetis Inc. operates in the Healthcare sector. The stock currently trades at $74.41 with a market capitalization of $51.8B. The stock has declined 38.8% over the past 52 weeks.
Analyst coverage from Morgan Stanley provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Zoetis Inc..
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Zoetis Inc.
Among the 10 most recent ratings: 5 Buy, 5 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Jul 22, 2026 | Morgan Stanley | Overweight | N/A |
| Jul 06, 2026 | HSBC | Buy | N/A |
| Jul 01, 2026 | Barclays | Equal-Weight | N/A |
| Jun 30, 2026 | TD Cowen | Buy | N/A |
| Jun 26, 2026 | Stifel | Hold | N/A |
Related Tools: Analyst Ratings Dashboard | View ZTS Stock Page
Frequently Asked Questions
What does a Overweight rating mean for ZTS?
A Overweight rating from Morgan Stanley reflects the analyst's outlook on Zoetis Inc. (NYSE:ZTS). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the ZTS forecast page.
